Company Overview
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Company Information
- CEO
- Stanley M. Bergman CPA
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Employees
- 25000
Contact Information
- Website
- https://www.henryschein.com
- Address
- 135 Duryea Road
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 8.21B market capitalization
- Trading Volume: 414.76K shares traded today
- Price Range: 52-week range of $60.56 - $82.49
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Henry Schein, Inc.
Henry Schein, Inc. (HSIC) operates in the Medical - Distribution industry within the Healthcare sector. With a current market capitalization of 8.21B, the company represents a significant player in its market. The stock is currently trading at $67.73 with a negativedaily change of 0.16%.
The company's 25000 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 21.78, beta of 0.82, and 52-week price range from $60.56 to $82.49when evaluating investment opportunities.
Why Invest in Henry Schein, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Stanley M. Bergman CPA
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.